Contract Pharma Manufacturing Services
-
Process Development: Mammalian, Bacteria And Yeast Based Success
2/17/2022
At AGC Biologics, we have developed over 200 mammalian, bacteria and yeast-based processes, giving us the insight necessary to identify and optimize process parameters that are critical for achieving a high-quality, cost-effective manufacturing process.
-
Antibody-Drug Conjugate
1/25/2024
EirGenix provides client-oriented contract development and manufacturing services for biologics, especially monoclonal antibodies and biosimilars. Combining the capabilities of EirGenix’s strategic partner, Formosa Laboratories, Inc, a high potency API manufacturer, we offer integrated services for Antibody Drug Conjugate (ADC) development and manufacturing.
-
Expertise, Experience, And Commitment Drives Results
2/28/2023
The BioCentriq team of experienced engineers, scientists, researchers, analysts, and operators have expertise in a variety of modalities, equipment, technologies, platforms, and processes.
-
PUREplatform PUREcoli, A Pure Microbial Strain For Protein Production
3/17/2023
PUREplatform offers a platform, a premium strain, and cutting-edge screening, which together yield optimal protein expression that is uniquely tailored to each project.
-
AGCellerate For mAbs
6/29/2023
AGC Biologics has released a new program designed to deliver effective IND-ready GMP material for biopharmaceutical developers. AGCellerate offers guaranteed amounts at fixed timelines and costs –accelerating projects through development and into clinical phases.
-
Integrated Drug Discovery
7/1/2023
Finding a partner with integrated services is crucial for accelerating timelines and accessing solutions with comprehensive expertise, all while removing risk from the drug product lifecycle.
-
Primary Drug Containers
2/10/2021
Oval’s proprietary primary drug containers offer a wide range of benefits over traditional glass based systems. The use of cyclic olefin copolymer (COC) allows for much greater design flexibility, and the creation of more robust containers, whilst also allowing us to remove materials that could potentially interact with the drug. Our COC primary drug container is used as the basis for our platforms ArQ®, ArQ® - Bios and ArQ® - Vita.
-
Modern GMP Manufacturing Suites, Pilot Plant, And Supporting Infrastructure
2/28/2023
BioCentriq owns and operates facilities that are designed exclusively for cell and gene therapy. All sites are fully equipped with standard equipment to manufacture autologous and allogeneic therapies using both open and closed processes. We have the quality systems and procedures in place to manufacture and release clinical grade material.
-
Cell Line Development
1/25/2024
EirGenix provides comprehensive cell line development services from DNA replication to the generation of stable producer cell lines for further process development and manufacturing. Our goal is to assist our clients in identifying the most favorable cell line expression system and provide optimization to achieve or surpass expected project targets.
-
cGMP Manufacturing - Mammalian System
1/25/2024
Review how a comprehensive cGMP manufacturing facility is poised to support the development and manufacture of your mammalian cell program.